Active Development. DS’ exclusivity, rights and licenses under the Commercial License will automatically expire if DS ceases all research and development of the Antibodies and Products for a period of […***…].
Appears in 2 contracts
Sources: Collaboration and Cross License Agreement (Zymeworks Inc.), Collaboration and Cross License Agreement (Zymeworks Inc.)